Evelo Biosciences to Present at Upcoming Investor Conferences in June

On May 26, 2021 Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, reported that management will present at three upcoming virtual investor conferences in June (Press release, Evelo Biosciences, MAY 26, 2021, View Source [SID1234580598]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual Healthcare Conference. Management will host a presentation at 1:30 p.m. ET on Wednesday, June 2, 2021.

JMP Securities Life Sciences Conference. Management will host a fireside chat at 1:00 p.m. ET on Wednesday, June 16, 2021.

Raymond James Human Health Innovation Conference. Management will host a presentation at 9:20 a.m. ET on Tuesday, June 22, 2021.

Live audio webcasts of the presentations will be available on the Investors section of the Evelo website at View Source A replay of these webcasts will be available for approximately 30 days following each presentation.